Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV Infection

Blood donations in South Africa are tested for HIV RNA using individual donation NAT (ID-NAT), allowing detection and rapid antiretroviral therapy (ART) of acute HIV infections. We enrolled a cohort of acute and recent HIV-infected blood donation candidates in South Africa in 2015–2018, measured HIV...

Full description

Bibliographic Details
Main Authors: Karin van den Berg, Marion Vermeulen, Sonia Bakkour, Mars Stone, Genevieve Jacobs, Cynthia Nyoni, Coreen Barker, Christopher McClure, Darryl Creel, Eduard Grebe, Nareg Roubinian, Ute Jentsch, Brian Custer, Michael P. Busch, Edward L. Murphy, on behalf of the Recipient Epidemiology and Donor Evaluation Study (REDS)-III South Africa International Program
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/14/11/2326
_version_ 1797466293159329792
author Karin van den Berg
Marion Vermeulen
Sonia Bakkour
Mars Stone
Genevieve Jacobs
Cynthia Nyoni
Coreen Barker
Christopher McClure
Darryl Creel
Eduard Grebe
Nareg Roubinian
Ute Jentsch
Brian Custer
Michael P. Busch
Edward L. Murphy
on behalf of the Recipient Epidemiology and Donor Evaluation Study (REDS)-III South Africa International Program
author_facet Karin van den Berg
Marion Vermeulen
Sonia Bakkour
Mars Stone
Genevieve Jacobs
Cynthia Nyoni
Coreen Barker
Christopher McClure
Darryl Creel
Eduard Grebe
Nareg Roubinian
Ute Jentsch
Brian Custer
Michael P. Busch
Edward L. Murphy
on behalf of the Recipient Epidemiology and Donor Evaluation Study (REDS)-III South Africa International Program
author_sort Karin van den Berg
collection DOAJ
description Blood donations in South Africa are tested for HIV RNA using individual donation NAT (ID-NAT), allowing detection and rapid antiretroviral therapy (ART) of acute HIV infections. We enrolled a cohort of acute and recent HIV-infected blood donation candidates in South Africa in 2015–2018, measured HIV antibody, ID-NAT, and recency of infection <195 days (Sedia LAg) at enrollment and initiated early ART. A small cohort of HIV elite controllers was followed without treatment. HIV reservoir measurements included ultrasensitive plasma RNA, cell-associated HIV RNA, and total DNA. Enrollment of 18 Fiebig I–III and 45 Fiebig IV–VI HIV clade C subjects occurred a median of 18 days after index blood donation. ART was administered successfully and compliance with follow-up visits was excellent. There were only minimal differences in HIV reservoir between ART initiation in Fiebig stages I–III vs. IV–VI, but ART noncompliance increased HIV reservoir. In 11 untreated HIV elite controllers, HIV reservoir levels were similar to or higher than those seen in our early treated cohort. National blood services can identify acute HIV cohorts for subsequent HIV cure research studies. Among HIV clade C-infected donors, HIV reservoir differed little by Fiebig stage at treatment initiation, but was smaller than in chronically treated HIV and those with ART noncompliance.
first_indexed 2024-03-09T18:33:48Z
format Article
id doaj.art-042cfeb0a4f34fafb19a0ef3d8bb0641
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-09T18:33:48Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-042cfeb0a4f34fafb19a0ef3d8bb06412023-11-24T07:15:25ZengMDPI AGViruses1999-49152022-10-011411232610.3390/v14112326Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV InfectionKarin van den Berg0Marion Vermeulen1Sonia Bakkour2Mars Stone3Genevieve Jacobs4Cynthia Nyoni5Coreen Barker6Christopher McClure7Darryl Creel8Eduard Grebe9Nareg Roubinian10Ute Jentsch11Brian Custer12Michael P. Busch13Edward L. Murphy14on behalf of the Recipient Epidemiology and Donor Evaluation Study (REDS)-III South Africa International ProgramSouth African National Blood Service, Johannesburg 3610, South AfricaSouth African National Blood Service, Johannesburg 3610, South AfricaVitalant Research Institute, San Francisco, CA 94118, USAVitalant Research Institute, San Francisco, CA 94118, USASouth African National Blood Service, Johannesburg 3610, South AfricaSouth African National Blood Service, Johannesburg 3610, South AfricaClinical HIV Research Unit, University of the Witwatersr, Johannesburg 2092, South AfricaRTI International, Rockville, MD 20852, USARTI International, Rockville, MD 20852, USAVitalant Research Institute, San Francisco, CA 94118, USAVitalant Research Institute, San Francisco, CA 94118, USASouth African National Blood Service, Johannesburg 3610, South AfricaVitalant Research Institute, San Francisco, CA 94118, USAVitalant Research Institute, San Francisco, CA 94118, USAVitalant Research Institute, San Francisco, CA 94118, USABlood donations in South Africa are tested for HIV RNA using individual donation NAT (ID-NAT), allowing detection and rapid antiretroviral therapy (ART) of acute HIV infections. We enrolled a cohort of acute and recent HIV-infected blood donation candidates in South Africa in 2015–2018, measured HIV antibody, ID-NAT, and recency of infection <195 days (Sedia LAg) at enrollment and initiated early ART. A small cohort of HIV elite controllers was followed without treatment. HIV reservoir measurements included ultrasensitive plasma RNA, cell-associated HIV RNA, and total DNA. Enrollment of 18 Fiebig I–III and 45 Fiebig IV–VI HIV clade C subjects occurred a median of 18 days after index blood donation. ART was administered successfully and compliance with follow-up visits was excellent. There were only minimal differences in HIV reservoir between ART initiation in Fiebig stages I–III vs. IV–VI, but ART noncompliance increased HIV reservoir. In 11 untreated HIV elite controllers, HIV reservoir levels were similar to or higher than those seen in our early treated cohort. National blood services can identify acute HIV cohorts for subsequent HIV cure research studies. Among HIV clade C-infected donors, HIV reservoir differed little by Fiebig stage at treatment initiation, but was smaller than in chronically treated HIV and those with ART noncompliance.https://www.mdpi.com/1999-4915/14/11/2326blood donorsHIV reservoirHIV cureHIV clade CSouth Africa
spellingShingle Karin van den Berg
Marion Vermeulen
Sonia Bakkour
Mars Stone
Genevieve Jacobs
Cynthia Nyoni
Coreen Barker
Christopher McClure
Darryl Creel
Eduard Grebe
Nareg Roubinian
Ute Jentsch
Brian Custer
Michael P. Busch
Edward L. Murphy
on behalf of the Recipient Epidemiology and Donor Evaluation Study (REDS)-III South Africa International Program
Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV Infection
Viruses
blood donors
HIV reservoir
HIV cure
HIV clade C
South Africa
title Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV Infection
title_full Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV Infection
title_fullStr Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV Infection
title_full_unstemmed Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV Infection
title_short Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV Infection
title_sort blood center testing allows the detection and rapid treatment of acute and recent hiv infection
topic blood donors
HIV reservoir
HIV cure
HIV clade C
South Africa
url https://www.mdpi.com/1999-4915/14/11/2326
work_keys_str_mv AT karinvandenberg bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT marionvermeulen bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT soniabakkour bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT marsstone bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT genevievejacobs bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT cynthianyoni bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT coreenbarker bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT christophermcclure bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT darrylcreel bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT eduardgrebe bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT naregroubinian bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT utejentsch bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT briancuster bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT michaelpbusch bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT edwardlmurphy bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection
AT onbehalfoftherecipientepidemiologyanddonorevaluationstudyredsiiisouthafricainternationalprogram bloodcentertestingallowsthedetectionandrapidtreatmentofacuteandrecenthivinfection